Manufacturer WIBP claims Sinopharm vaccine has 72.5 percent efficacy rate

Redfield saysmost likely etiology of this pathogen in Wuhan was from a laboratory

Analysts suspect Sinopharm labs biowarfare pedigree points to dual-use research